Suptavumab Antibody
Suptavumab (REGN2222) is a human monoclonal antibody that neutralizes respiratory syncytial virus (RSV) by targeting conserved epitopes on subtypes A and B. It is a valuable research tool for studying RSV pathogenesis and evaluating antiviral strategies in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
Suptavumab, RSV, REGN2222, REGN-2222, REGN 2222
Target
RSV
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Concentration
3.15 mg/mL
Purity
96.40% (May vary between batches)
Molecular Weight
146.04 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
